- Record: found
- Abstract: not found
- Article: not found
A long term safty extenion trial of the farnesoid X receptor (FXR) agonist obeticholic acid (OCA) and UDCA in pimary biliary cirrhosis (PBC)
Read this article at
ScienceOpen
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.